North America Gastrointestinal Diseases Drug Development Market (2025-2031) | Supply, Challenges, Trends, Forecast, Pricing Analysis, Segments, Investment Trends, Value, Competition, Strategy, Size, Opportunities, Strategic Insights, Industry, Drivers, Revenue, Competitive, Growth, Restraints, Outlook, Companies, Share, Analysis, Consumer Insights, Demand, Segmentation

Market Forecast by Countries (United States (US), Canada, Rest of North America), By Disease Type (Gastroenteritis, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome, Others), By Molecular Targets (Sodium Transporter NHE3 Inhibitor, Sphinogosine-1-Phosphate Receptor Functional Antagonist, Tumor Necrosis Factor (TNF) Blocker, Others), By Marketed Drugs (Infliximab, Adalimumab, Mesalazine, Others), By Clinical Trials (Etrolizumab, SHP647, ABX464, ASP3291, Others), By Route of Administration (Oral, Injectable), By End-Users (Hospitals, Homecare, Specialty Clinics) And Competitive Landscape
Product Code: ETC13276105 Publication Date: Apr 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 150 No. of Figures: 55 No. of Tables: 32

Key Highlights of the Report:

  • North America Gastrointestinal Diseases Drug Development Market Outlook
  • Market Size of North America Gastrointestinal Diseases Drug Development Market, 2024
  • Forecast of North America Gastrointestinal Diseases Drug Development Market, 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Revenues & Volume for the Period 2021 - 2031
  • North America Gastrointestinal Diseases Drug Development Market Trend Evolution
  • North America Gastrointestinal Diseases Drug Development Market Drivers and Challenges
  • North America Gastrointestinal Diseases Drug Development Price Trends
  • North America Gastrointestinal Diseases Drug Development Porter's Five Forces
  • North America Gastrointestinal Diseases Drug Development Industry Life Cycle
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Gastroenteritis for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Inflammatory Bowel Disease (IBD) for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Irritable Bowel Syndrome for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Gastroenteritis for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Inflammatory Bowel Disease (IBD) for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Irritable Bowel Syndrome for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Gastroenteritis for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Inflammatory Bowel Disease (IBD) for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Irritable Bowel Syndrome for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Gastroenteritis for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Inflammatory Bowel Disease (IBD) for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Irritable Bowel Syndrome for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Molecular Targets for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sodium Transporter NHE3 Inhibitor for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sphinogosine-1-Phosphate Receptor Functional Antagonist for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Tumor Necrosis Factor (TNF) Blocker for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Molecular Targets for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sodium Transporter NHE3 Inhibitor for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sphinogosine-1-Phosphate Receptor Functional Antagonist for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Tumor Necrosis Factor (TNF) Blocker for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Molecular Targets for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sodium Transporter NHE3 Inhibitor for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sphinogosine-1-Phosphate Receptor Functional Antagonist for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Tumor Necrosis Factor (TNF) Blocker for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Molecular Targets for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sodium Transporter NHE3 Inhibitor for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Sphinogosine-1-Phosphate Receptor Functional Antagonist for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Tumor Necrosis Factor (TNF) Blocker for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Marketed Drugs for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Infliximab for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Adalimumab for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Mesalazine for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Marketed Drugs for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Infliximab for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Adalimumab for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Mesalazine for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Marketed Drugs for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Infliximab for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Adalimumab for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Mesalazine for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Marketed Drugs for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Infliximab for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Adalimumab for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Mesalazine for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Clinical Trials for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Etrolizumab for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By SHP647 for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By ABX464 for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By ASP3291 for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Clinical Trials for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Etrolizumab for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By SHP647 for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By ABX464 for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By ASP3291 for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Clinical Trials for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Etrolizumab for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By SHP647 for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By ABX464 for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By ASP3291 for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Clinical Trials for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Etrolizumab for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By SHP647 for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By ABX464 for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By ASP3291 for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Oral for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Injectable for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Oral for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Injectable for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Oral for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Injectable for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Oral for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Injectable for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By End-Users for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Hospitals for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Homecare for the Period 2021 - 2031
  • Historical Data and Forecast of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Specialty Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By End-Users for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Hospitals for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Homecare for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Gastrointestinal Diseases Drug Development Market Revenues & Volume By Specialty Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By End-Users for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Hospitals for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Homecare for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Gastrointestinal Diseases Drug Development Market Revenues & Volume By Specialty Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By End-Users for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Hospitals for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Homecare for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Gastrointestinal Diseases Drug Development Market Revenues & Volume By Specialty Clinics for the Period 2021 - 2031
  • North America Gastrointestinal Diseases Drug Development Market - Key Performance Indicators
  • North America Gastrointestinal Diseases Drug Development Market - Import Export Trade Statistics
  • North America Gastrointestinal Diseases Drug Development Market - Opportunity Assessment By Countries
  • North America Gastrointestinal Diseases Drug Development Market - Opportunity Assessment By Disease Type
  • North America Gastrointestinal Diseases Drug Development Market - Opportunity Assessment By Molecular Targets
  • North America Gastrointestinal Diseases Drug Development Market - Opportunity Assessment By Marketed Drugs
  • North America Gastrointestinal Diseases Drug Development Market - Opportunity Assessment By Clinical Trials
  • North America Gastrointestinal Diseases Drug Development Market - Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-Users
  • North America Gastrointestinal Diseases Drug Development Market - Top Companies Market Share
  • North America Gastrointestinal Diseases Drug Development Market - Top Companies Profiles
  • North America Gastrointestinal Diseases Drug Development Market - Comparison of Players in Technical and Operating Parameters
  • North America Gastrointestinal Diseases Drug Development Market - Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the North America Gastrointestinal Diseases Drug Development Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the North America Gastrointestinal Diseases Drug Development Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

North America Gastrointestinal Diseases Drug Development Market

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 North America Gastrointestinal Diseases Drug Development Market Overview

3.1 North America Regional Macro Economic Indicators

3.2 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume, 2021 & 2031F

3.3 North America Gastrointestinal Diseases Drug Development Market - Industry Life Cycle

3.4 North America Gastrointestinal Diseases Drug Development Market - Porter's Five Forces

3.5 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Countries, 2021 & 2031F

3.6 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.7 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Molecular Targets, 2021 & 2031F

3.8 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Marketed Drugs, 2021 & 2031F

3.9 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Clinical Trials, 2021 & 2031F

3.10 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.11 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4 North America Gastrointestinal Diseases Drug Development Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 North America Gastrointestinal Diseases Drug Development Market Trends

6 North America Gastrointestinal Diseases Drug Development Market, 2021 - 2031

6.1 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Disease Type, 2021 - 2031

6.1.1 Overview & Analysis

6.1.2 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Gastroenteritis, 2021 - 2031

6.1.3 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Inflammatory Bowel Disease (IBD), 2021 - 2031

6.1.4 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Irritable Bowel Syndrome, 2021 - 2031

6.1.5 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Others, 2020 - 2028

6.2 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Molecular Targets, 2021 - 2031

6.2.1 Overview & Analysis

6.2.2 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Sodium Transporter NHE3 Inhibitor, 2021 - 2031

6.2.3 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Sphinogosine-1-Phosphate Receptor Functional Antagonist, 2021 - 2031

6.2.4 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Tumor Necrosis Factor (TNF) Blocker, 2021 - 2031

6.2.5 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Others, 2021 - 2031

6.3 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Marketed Drugs, 2021 - 2031

6.3.1 Overview & Analysis

6.3.2 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Infliximab, 2021 - 2031

6.3.3 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Adalimumab, 2021 - 2031

6.3.4 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Mesalazine, 2021 - 2031

6.3.5 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Others, 2021 - 2031

6.4 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Clinical Trials, 2021 - 2031

6.4.1 Overview & Analysis

6.4.2 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Etrolizumab, 2021 - 2031

6.4.3 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By SHP647, 2021 - 2031

6.4.4 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By ABX464, 2020 - 2028

6.4.5 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By ASP3291, 2020 - 2028

6.4.6 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Others, 2020 - 2028

6.5 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Route of Administration, 2020 - 2028

6.5.1 Overview & Analysis

6.5.2 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Oral, 2020 - 2028

6.5.3 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Injectable, 2020 - 2028

6.6 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By End-Users, 2020 - 2028

6.6.1 Overview & Analysis

6.6.2 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Hospitals, 2020 - 2028

6.6.3 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Homecare, 2020 - 2028

6.6.4 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Specialty Clinics, 2020 - 2028

7 North America Gastrointestinal Diseases Drug Development Market, By Countries, 2021 - 2031

7.1 Overview & Analysis

7.2 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.2.1 United States (US) Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.2.2 Canada Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.2.3 Rest of North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.3 North America Gastrointestinal Diseases Drug Development Market Revenues & Volume Share, By Molecular Targets, 2021 & 2031F

7.3.1 United States (US) Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Molecular Targets, 2021 - 2031

7.3.2 Canada Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Molecular Targets, 2021 - 2031

7.3.3 Rest of North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Molecular Targets, 2021 - 2031

7.4 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Marketed Drugs, 2021 - 2031

7.4.1 United States (US) Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Marketed Drugs, 2021 - 2031

7.4.2 Canada Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Marketed Drugs, 2021 - 2031

7.4.3 Rest of North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Marketed Drugs, 2021 - 2031

7.5 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Clinical Trials, 2021 - 2031

7.5.1 United States (US) Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Clinical Trials, 2021 - 2031

7.5.2 Canada Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Clinical Trials, 2021 - 2031

7.5.3 Rest of North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Clinical Trials, 2021 - 2031

7.6 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7.6.1 United States (US) Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7.6.2 Canada Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7.6.3 Rest of North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7.7 North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By End-Users, 2021 - 2031

7.7.1 United States (US) Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By End-Users, 2021 - 2031

7.7.2 Canada Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By End-Users, 2021 - 2031

7.7.3 Rest of North America Gastrointestinal Diseases Drug Development Market, Revenues & Volume, By End-Users, 2021 - 2031

8 North America Gastrointestinal Diseases Drug Development Market Key Performance Indicators

9 North America Gastrointestinal Diseases Drug Development Market - Export/Import By Countries Assessment

10 North America Gastrointestinal Diseases Drug Development Market - Opportunity Assessment

10.1 North America Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Countries, 2021 & 2031F

10.2 North America Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Disease Type, 2021 & 2031F

10.3 North America Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Molecular Targets, 2021 & 2031F

10.4 North America Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Marketed Drugs, 2021 & 2031F

10.5 North America Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Clinical Trials, 2021 & 2031F

10.6 North America Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

10.7 North America Gastrointestinal Diseases Drug Development Market Opportunity Assessment, By End-Users, 2021 & 2031F

11 North America Gastrointestinal Diseases Drug Development Market - Competitive Landscape

11.1 North America Gastrointestinal Diseases Drug Development Market Revenue Share, By Companies, 2022

11.2 North America Gastrointestinal Diseases Drug Development Market Competitive Benchmarking, By Operating and Technical Parameters

12 Top 10 Company Profiles

13 Recommendations

14 Disclaimer

Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All